Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.03% inched 0.38% higher to $165.42 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.29% rising 0.85% to 4,480.70 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.35% rising 0.68% to 34,814.39. The stock's rise snapped a six-day losing streak. Johnson & Johnson closed $14.50 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -1.64% fell 0.76% to $371.89, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.64% rose 0.97% to $72.81, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.61% rose 0.13% to $44.77. Trading volume (7.5 M) eclipsed its 50-day average volume of 5.6 M.